Virios Therapeutics Inc (VIRI)

[McMagyar]

They would have raised money last week when they traded 111,000 000…
At $1.40..
why didn’t they?

Because..

Because why?

Because we don’t understand the phase 2 data and how successfully it effecs treatment Naieve patients..
And what that means for market potential..

And how well their phase 1 open label safety and efficacy trial is going ..


Otherwise they absolutely would have pulled the trigger on equity raise..